Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Infinity Pharmaceuticals (INFI)

Infinity Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INFI
DateTimeSourceHeadlineSymbolCompany
13/09/202312:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
12/09/202322:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INFIInfinity Pharmaceuticals Inc
11/09/202320:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
01/09/202320:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
10/08/202320:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INFIInfinity Pharmaceuticals Inc
25/07/202320:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
25/07/202320:05Business WireInfinity Pharmaceuticals Announces Value Preservation and Maximization PlanNASDAQ:INFIInfinity Pharmaceuticals Inc
24/07/202312:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
24/07/202312:30Business WireInfinity Pharmaceuticals Announces Termination of Merger Agreement with MEI PharmaNASDAQ:INFIInfinity Pharmaceuticals Inc
14/07/202320:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
14/07/202317:00Business WireInfinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI PharmaNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202312:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202312:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202312:30Business WireInfinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)NASDAQ:INFIInfinity Pharmaceuticals Inc
05/07/202312:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
05/07/202312:30Business WireISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.NASDAQ:INFIInfinity Pharmaceuticals Inc
03/07/202320:57Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:INFIInfinity Pharmaceuticals Inc
03/07/202320:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
03/07/202312:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
30/06/202320:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
29/06/202310:01Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
27/06/202312:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
21/06/202312:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
20/06/202312:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
20/06/202312:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INFIInfinity Pharmaceuticals Inc
16/06/202316:34Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
16/06/202312:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
15/06/202316:08Business WireMEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology CandidatesNASDAQ:INFIInfinity Pharmaceuticals Inc
15/06/202312:00Business WireMEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology CandidatesNASDAQ:INFIInfinity Pharmaceuticals Inc
06/06/202320:44Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:INFI

Your Recent History

Delayed Upgrade Clock